M. Palmer

发表

Trends in Lipids, Obesity, Metabolic Syndrome, and Diabetes Mellitus in the United States: An NHANES Analysis (2003‐2004 to 2013‐2014)

P. Toth, M. Palmer, 2019, Obesity.

Efficacy and safety of rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: results of the POLARIS study.

Lawrence A Leiter, R. Rosenson, E. Stein, 2007, Atherosclerosis.

Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database

P. Barter, G. Brandrup-Wognsen, S. Nicholls, 2010, Journal of Lipid Research.

Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study

D. Grobbee, M. Bots, G. Evans, 2009, Journal of internal medicine.

Extensive or restricted ultrasound protocols to measure carotid intima-media thickness: analysis of completeness rates and impact on observed rates of change over time.

S. Peters, D. Grobbee, M. Bots, 2012, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.

Diederick E Grobbee, Michiel L Bots, D. Grobbee, 2007, JAMA.

A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia.

P. Barter, S. Nicholls, B. Karlson, 2016, The American journal of cardiology.

Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)

J. Amerena, J. Bassand, M. Clearfield, 2006, Trials.

Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER).

P. Barter, G. Brandrup-Wognsen, S. Nicholls, 2010, The American journal of cardiology.

A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia.

D. Rader, F. Raal, A. Marais, 2008, Atherosclerosis.

To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis.

P. Barter, S. Nicholls, B. Karlson, 2015, Atherosclerosis.

Increased age, high body mass index and low HDL‐C levels are related to an echolucent carotid intima–media: the METEOR study

S. Peters, D. Grobbee, L. Lind, 2012, Journal of internal medicine.

Abstract: P952 C-REACTIVE PROTEIN LOWERING WITH ROSUVASTATIN IN THE METEOR STUDY

D. Grobbee, M. Bots, G. Evans, 2009 .

Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.

S. Peters, D. Grobbee, L. Lind, 2012, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Achievement of 2011 European low-density lipoprotein cholesterol (LDL-C) goals of either <70 mg/dl or ≥ 50% reduction in high-risk patients: results from VOYAGER.

P. Barter, S. Nicholls, B. Karlson, 2013, Atherosclerosis.

Effects of age, gender and statin dose on lipid levels: Results from the VOYAGER meta-analysis database.

P. Barter, S. Nicholls, B. Karlson, 2017, Atherosclerosis.

Modeling Statin-Induced Reductions of Cardiovascular Events in Primary Prevention: A VOYAGER Meta-Analysis

P. Barter, S. Nicholls, B. Karlson, 2018, Cardiology.

Achievement of LDL-C goals depends on baseline LDL-C and choice and dose of statin: An analysis from the VOYAGER database

P. Barter, S. Nicholls, B. Karlson, 2013, European journal of preventive cardiology.

Original article Biologically implausible carotid intima-media thickness measurement values: effects on rate of change over time

S. Peters, D. Grobbee, H. Ruijter, 2012 .

Multiple imputation of missing repeated outcome measurements did not add to linear mixed-effects models.

Diederick E Grobbee, Michiel L Bots, Hendrik Koffijberg, 2012, Journal of clinical epidemiology.

Sample size requirements in trials using repeated measurements and the impact of trial design

S. Peters, D. Grobbee, M. Bots, 2012, Current medical research and opinion.

The use of plaque score measurements to assess changes in atherosclerotic plaque burden induced by lipid-lowering therapy over time: the METEOR study.

S. Peters, D. Grobbee, M. Bots, 2011, Journal of atherosclerosis and thrombosis.

Does baseline carotid intima–media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima–media thickness progression? The METEOR study

D. Grobbee, M. Bots, G. Evans, 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: results from VOYAGER.

P. Barter, S. Nicholls, B. Karlson, 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin in Subclinical Atherosclerosis—The Rationale and Methodology of the METEOR Study

Diederick E. Grobbee, Joel S. Raichlen, Michiel L. Bots, 2004, Cardiovascular Drugs and Therapy.

Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER.

P. Barter, O. Wiklund, S. Nicholls, 2016, European heart journal. Cardiovascular pharmacotherapy.

Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis.

P. Barter, S. Nicholls, B. Karlson, 2019, Clinical biochemistry.

Asymmetrical distribution of atherosclerosis in the carotid artery: identical patterns across age, race, and gender

S. Peters, D. Grobbee, M. Bots, 2012, European journal of preventive cardiology.

Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysis

P. Barter, S. Nicholls, B. Karlson, 2016, European journal of preventive cardiology.